mo

Molina Healthcare

MOH
NYSE
$149.74

How effective is Molina Healthcare's capital allocation strategy?

Molina Healthcare's capital allocation score of 76 out of 100 is commendable, reflecting management's effective deployment of resources.

The impressive 5Y Revenue CAGR of 18.5% suggests successful investments in expanding market share and membership, likely through a combination of organic growth in existing and new state Medicaid markets, as well as strategic acquisitions.

This growth points to management's ability to identify and execute on opportunities within their specialized managed care segments. The exceptionally high TTM ROE of 57.5% further supports a view of strong capital efficiency.

While the 5Y Net Income CAGR is negative, indicating some profitability challenges over that period, the overall high score suggests that long-term strategic investments and efficient use of capital are generating substantial value for shareholders, even amidst the thin margins characteristic of the managed care industry.

The moderate Debt/Equity ratio of 0.87x also indicates a balanced approach to financing growth and returns.